Royalty Pharma plcRPRXNASDAQ

|||

Overview News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Alerts

Want to monitor RPRX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor RPRX

Key Statistics

About

royalty pharma is the industry leader in acquiring revenue-producing intellectual property – principally royalty interests in marketed and late stage biopharmaceutical products with $13 billion in assets. since inception in 1996, royalty pharma and its predecessors have invested approximately $5. 8 billion to assemble a leading portfolio of royalty interests in pharmaceutical and biopharmaceutical products.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

CEO

Pablo Gerardo Legorreta

royaltypharma.com →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

Watch February Earnings From NVIDIA and Microsoft to Predict Where This Mag7 ETF Goes Next

Talen Energy Corporation (TLN) Soars 11.8%: Is Further Upside Left in the Stock?

Is Pacer US Cash Cows 100 ETF (COWZ) a Strong ETF Right Now?

Is Invesco S&P MidCap 400 GARP ETF (GRPM) a Strong ETF Right Now?

Should iShares S&P Small-Cap 600 Value ETF (IJS) Be on Your Investing Radar?

Is State Street SPDR Russell 1000 Yield Focus ETF (ONEY) a Strong ETF Right Now?

Should iShares MSCI USA Min Vol Factor ETF (USMV) Be on Your Investing Radar?

Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?

Should Vanguard Small-Cap ETF (VB) Be on Your Investing Radar?

Is iShares MSCI USA Quality Factor ETF (QUAL) a Strong ETF Right Now?

Is WisdomTree U.S. High Yield Corporate Bond ETF (QHY) a Strong ETF Right Now?

Mechanics Bancorp Announces Date of Fourth Quarter 2025 Earnings Release and Conference Call

Why Joby Aviation Is A Prime Pick For Speculative Investors

Starlink-rival Eutelsat signs deal with Europe's MaiaSpace to launch satellites

National Health Investors: A Healthcare REIT Ready For The Senior Housing Supercycle

Flowers Foods: The Selloff Has Gone Too Far, I'm Buying

Close Brothers jumps 6% after RBC upgrades bank on cost-cutting scope

TechnipFMC Energized by Huge Inflows

PNC Profit Rises as Loans Increase

AST SpaceMobile Stock Jumps Again. Why the SpaceX Rival's Shares Are Going Stellar.